A research team from Trinity College Dublin has unveiled a new approach to vaccination that could redefine how we protect against respiratory infections. In a study published in Nature Microbiology, ...

Q3 2025 Management View CEO Ryan Spencer highlighted top line growth and market share expansion for HEPLISAV-B, the advancement of multiple clinical programs, execution of a strategic license with ...

Reports third quarter revenue of $1.0 billion, GAAP net loss of $(0.2) billion and GAAP EPS of $(0.51) Narrows 2025 projected ...

Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today reported financial results and provided a ...

On September 18th, the Centers for Disease Control and Prevention's vaccine advisory committee voted to make a significant change to the nation's childhood vaccine schedule during its first gathering ...

A research team from Trinity has unveiled a groundbreaking new approach to vaccination that could redefine how we protect against respiratory infections.

Share on Pinterest A new CDC panel voted to make changes to childhood vaccination schedules and further narrow recommendations for COVID-19 shots. Shutterstock The acting CDC director suggested the ...

LB Pharmaceuticals and Celldex have separately stepped up their respective launch preparations by appointing new chief commercial officers, according to a pair of announcements this week. | LB ...

Quarter Highlighted by GEO-MVA Acceleration Amid Global Mpox Emergency, Gedeptin(R) Expansion Into New Solid Tumor Programs, and Strong GEO-CM04S1 Clinical Data in Immunocompromised Patients Company ...